Certified by Founder
Lodge
Santa Ana Bio, Inc.
start up
United States
- Alameda, California
- 14/06/2024
- Series A
- $168,000,000
Santa Ana Bio is a Bay Area biotech focused on leveraging it’s multiomics and protein engineering platforms to design precision biologics for the treatment of patients with serious immune related diseases.
- Industry Biotechnology Research
- Website https://www.santaanabio.com/
- LinkedIn https://www.linkedin.com/company/santaanabio/
catalyx space | $5,400,000 | (Nov 4, 2025)
Zeeg | $1,265,935 | (Nov 4, 2025)
xMEMS | $21,000,000 | (Nov 4, 2025)
Cephia AI | $4,000,000 | (Nov 4, 2025)
Ornn | $5,700,000 | (Nov 4, 2025)
octonomy | $20,000,000 | (Nov 4, 2025)
Helex | $3,500,000 | (Nov 4, 2025)
Indomo | $25,000,000 | (Nov 4, 2025)
AUI™ (Augmented Intelligence) | $20,000,000 | (Nov 4, 2025)
Popai Health | $11,000,000 | (Nov 4, 2025)
Mem0 | $24,000,000 | (Oct 30, 2025)
FrontlineIQ | $3,300,000 | (Oct 30, 2025)